- Expertise article
- FA Zuckerman, MR Roof, E Vaughn, W Johnson
Country: United States
Source: 2008 Allen D. Leman Swine Conference
Challenge strain(s): MN 184
Key points:
- The objective of this study was to evaluate several adjuvants and/or immunomodulators in combination with Ingelvac PRRS MLV and investigate potential clinical or immunological improvements in vivo.
- The results of this study confirmed that in a severe heterologous virulent challenge respiratory model, Ingelvac PRRS MLV provided significant levels of protection.